1 Global Nasogastric Tube Market Insight Analysis
The global nasogastric tube market is valued at USD 260.55 million in 2024, with a CAGR of 3.60% from 2024 to 2033.
A nasogastric tube, often abbreviated as NG tube, is a flexible tube made of rubber or plastic that is inserted through the nose, down the nasopharynx and esophagus, and into the stomach. It serves multiple purposes, including the administration of nutrients and medications directly into the stomach, as well as the removal of stomach contents for decompression or diagnostic purposes. This versatile device is essential in various medical scenarios, particularly for patients who have difficulty swallowing or require specialized nutritional support.
Figure Global Nasogastric Tube Market Size (M USD) and CAGR (2024-2033)
2 Nasogastric Tube Market Growth Drivers and Restraints
With the aging of the global population and the rising incidence of chronic diseases, the demand for nasogastric tubes has increased significantly. Elderly people and patients with chronic diseases often have problems such as dysphagia and need nasogastric tubes for nutritional support and drug delivery. At the same time, the increase in the number of premature babies has also driven market growth. Premature babies need nasogastric tubes to obtain nutrition because their body functions are not fully developed.
Nasogastric tubes are constantly innovating in materials, design and functions. New materials such as polyurethane with better biocompatibility are widely used to reduce irritation to the patient’s body and the occurrence of complications. In terms of design, nasogastric tubes with special structures, such as those with multiple side holes and anti-reflux devices, improve the safety and convenience of use. These technological advances have improved the performance of nasogastric tubes and expanded their scope of application.
Nasogastric tubes are not only used for nutritional support and drug delivery, but are also increasingly used in some special medical scenarios. For example, before and after some surgical operations, nasogastric tubes can be used to decompress the gastrointestinal tract and promote patient recovery. In addition, nasogastric tubes can also play an important role in some emergency scenarios, which further increases the market demand for nasogastric tubes.
There may be a variety of side effects and complications during the use of nasogastric tubes, such as skin irritation, tube displacement, perforation, nausea and vomiting. These problems not only bring pain to patients, but also may affect the treatment effect, resulting in a decrease in patients’ acceptance of nasogastric tubes, thereby limiting the growth of the market.
The insertion and use of nasogastric tubes require certain professional skills, and improper operation may lead to serious consequences. Some medical staff are not proficient in operation, which may lead to problems such as difficulty in intubation and damage to patient tissues. This not only increases medical risks, but also limits the use of nasogastric tubes.
The market competition is fierce, and many companies may lead to uneven product quality in order to compete for market share. At the same time, factors such as fluctuations in raw material prices and rising labor costs have increased the production costs of enterprises, compressed profit margins, affected the company’s R&D investment and market expansion capabilities, and had an adverse impact on market growth.
3 Technological Innovations in the Nasogastric Tube Market
To improve the performance and safety of nasogastric tubes, material innovation is the key. At present, more and more nasogastric tubes are made of biocompatible, soft and durable materials, such as polyurethane and silicone. These materials can reduce irritation to the patient’s nasal cavity, throat and gastrointestinal tract, reduce the risk of infection, and at the same time improve the flexibility and durability of the nasogastric tube and extend its service life.
In terms of design, nasogastric tubes are constantly improved to meet clinical needs. For example, some nasogastric tubes have added special structures, such as scale marks, which are convenient for medical staff to accurately judge the insertion depth; the multi-cavity design can simultaneously achieve multiple functions such as nutrition delivery, gas discharge and drug injection; and some nasogastric tubes have special shapes designed at the front end, such as round and smooth heads, to reduce damage to tissues.
With the development of science and technology, the combination of monitoring technology and nasogastric tubes has become a new trend. Some nasogastric tubes have built-in sensors that can monitor parameters such as pressure and pH value in the gastrointestinal tract in real time, helping medical staff to adjust treatment plans in time and improve treatment effects. In addition, some smart nasogastric tubes can also send data to terminal devices through wireless transmission technology to achieve remote monitoring.
4 Global Nasogastric Tube Market Size by Type
Levin tubes are single-lumen, small-bore nasogastric tubes primarily used for the administration of medications or nutrition directly into the stomach. They are particularly popular in healthcare institutions due to their ease of use and lower complication rates. In 2024, the market revenue for Levin tubes is projected to reach $134.39 million USD, accounting for approximately 51.6% of the total market value. This segment is expected to grow steadily due to its widespread usage in hospitals and clinics, especially for pediatric and adult patients requiring enteral nutrition.
Sengstaken-Blakemore tubes are specialized nasogastric tubes designed to control bleeding from esophageal or gastric varices. These tubes are more complex and are used in critical care settings to manage severe medical conditions. In 2024, the market revenue for Sengstaken-Blakemore tubes is expected to be $74.12 million USD, representing about 28.4% of the total market value. The demand for these tubes is driven by the increasing number of patients with gastrointestinal bleeding disorders, particularly in aging populations.
Table Global Nasogastric Tube Market Size by Type in 2024
Type | Market Size (M USD) 2024 |
|---|---|
Levin tube | 134.39 |
Sengstaken-Blakemore tube | 74.12 |
Others | 52.04 |
5 Global Nasogastric Tube Market Size by Application
In 2024, the market revenue for nasogastric tubes in pediatric applications is projected to reach approximately $69.85 million. Nasogastric tubes play a vital role in pediatric care, especially for neonates and infants who may have difficulty swallowing or require additional nutritional support. Premature babies, in particular, often rely on these tubes to receive essential nutrients for growth and development. For example, in neonatal intensive care units (NICUs), nasogastric tubes are used to deliver breast milk or formula directly to the stomach.
This method ensures that premature infants, whose digestive systems may not be fully developed, can still receive proper nourishment. The growth in the number of premature births globally, along with an increased focus on improving pediatric healthcare, contributes significantly to the revenue in this segment. Additionally, the development of specialized nasogastric tubes for children, such as smaller diameter tubes with softer materials to minimize discomfort, further drives the market for pediatric applications.
The adult use segment is expected to generate a substantially higher revenue, estimated at around $190.69 million in 2024. Nasogastric tubes are widely used in adult patients who experience swallowing difficulties due to various reasons, including neurological disorders, head and neck surgeries, or chronic diseases. For patients with conditions like stroke, dementia, or amyotrophic lateral sclerosis (ALS), nasogastric tubes are essential for providing liquid nutrition and medications.
In hospitals and long – term care facilities, these tubes help ensure that patients receive adequate sustenance and treatment when they are unable to consume food or medications orally. The aging population, which is more prone to such health issues, is a major factor contributing to the growth of the adult use segment. Moreover, the increasing prevalence of chronic diseases among adults, such as diabetes and cancer, which can lead to swallowing problems as a complication, also drives the demand for nasogastric tubes in this segment.
Table Global Nasogastric Tube Market Size by Application in 2024
Application | Market Size (M USD) 2024 |
|---|---|
Children Use | 69.85 |
Adult Use | 190.69 |
6 Global Nasogastric Tube Market Size by Region
North America, particularly the United States and Canada, remains a dominant region in the nasogastric tube market. In 2024, the United States is projected to have a market revenue of approximately $72.60 million. The country’s well – developed healthcare system, high healthcare expenditure, and a large patient population contribute to this significant revenue. The presence of major market players like BD and Cardinal Health, which have a stronghold in the domestic market, also drives the growth. These companies benefit from advanced manufacturing capabilities, extensive distribution networks, and a focus on research and development.
Canada, on the other hand, is expected to generate around $7.58 million in revenue. Canada’s high – quality healthcare services and a population that values healthcare contribute to its share in the market. However, compared to the United States, Canada’s smaller population and a more centralized healthcare system result in a relatively lower market revenue.
Asia is a rapidly growing region in the nasogastric tube market. China, with its large population and a growing economy, is expected to reach a market revenue of about $51.06 million in 2024. The country’s increasing investment in healthcare infrastructure, improving access to medical services, and a growing awareness of the importance of proper medical treatment are fueling the market growth. Additionally, domestic companies like Guangdong Baihe Medical Technology are expanding their market share both locally and globally, contributing to China’s revenue growth.
Japan is projected to have a market revenue of around $19.96 million. Japan’s advanced medical technology, high – quality healthcare, and an aging population drive the demand for nasogastric tubes. India, with its large and growing population, is expected to generate approximately $9.43 million in revenue. Although India’s healthcare infrastructure is still developing in some areas, the increasing focus on improving healthcare access and quality, especially in rural areas, is leading to a rise in the demand for nasogastric tubes.
Europe also holds a significant share in the global nasogastric tube market. Germany is expected to have a market revenue of around $16.64 million in 2024. Germany’s strong healthcare system, high – tech medical industry, and a large number of hospitals and clinics contribute to its market share. The country’s focus on research and development in medical devices also enables it to offer high – quality nasogastric tubes.
The UK is projected to generate about $9.78 million in revenue. The UK’s well – established healthcare infrastructure and a growing awareness of patient – centered care drive the demand for nasogastric tubes. France and Italy are also important markets in Europe, with projected revenues of approximately $12.55 million and $9.76 million respectively. These countries have a significant patient population in need of medical devices, and their healthcare systems play a crucial role in driving the market.
Figure Global Nasogastric Tube Market Size (M USD) by Region in 2024
7 Global Nasogastric Tube Market Analysis by Major Players
7.1 BD
Company Introduction and Business Overview:
BD, founded in 1897 and headquartered in Franklin Lakes, New Jersey, is a leading multinational medical technology company. It employs nearly 70,000 people across more than 50 countries, manufacturing and distributing medical devices, instrument systems, and reagents.
BD is renowned for its innovative medical technologies and solutions, catering to a wide range of healthcare needs globally. The company’s extensive product portfolio includes nasogastric tubes, which are crucial for providing nutritional support and managing gastrointestinal issues in patients. BD’s commitment to research and development ensures that its products are at the forefront of medical technology.
Products:
BD offers a variety of nasogastric tubes, including dual-lumen tubes designed for efficient suction and irrigation. These tubes are made from high-quality materials to ensure patient safety and comfort. BD’s nasogastric tubes are widely used in hospitals and clinics worldwide due to their reliability and effectiveness.
Market Performance in 2021:
In 2021, BD’s nasogastric tube business generated a revenue of $95.44 million USD with a gross profit of $62.26 million USD, reflecting a gross profit margin of 65.23%.
7.2 Cardinal Health
Company Introduction and Business Overview:
Cardinal Health, established in 1917 and headquartered in Dublin, Ohio, is a global distributor of pharmaceuticals and medical products. The company is known for its comprehensive range of medical and laboratory products, as well as performance and data solutions for healthcare facilities.
Cardinal Health operates in multiple segments, including pharmaceutical distribution, medical products, and performance and data solutions. Its medical products division focuses on providing high-quality medical devices and supplies, including nasogastric tubes, which are essential for patient care in various medical settings. Cardinal Health’s extensive distribution network ensures that its products reach healthcare providers efficiently.
Products:
Cardinal Health offers a range of nasogastric tubes, including the Salem Sump™ Tube, which features a double-lumen design for effective suction drainage and gastric decompression. These tubes are designed to minimize patient discomfort and ensure reliable performance in clinical settings.
Market Performance in 2021:
In 2021, Cardinal Health’s nasogastric tube business achieved a revenue of $87.27 million USD with a gross profit of $56.18 million USD, resulting in a gross profit margin of 64.37%.
7.3 Guangdong Baihe
Company Introduction and Business Overview:
Founded in 1999 and headquartered in Foshan City, China, Guangdong Baihe Medical Technology is a leading manufacturer of disposable medical consumables. The company is known for its innovative products and strong market presence in the field of medical devices, particularly in nasogastric tubes.
Guangdong Baihe Medical Technology specializes in the research, development, and production of disposable medical devices. Its products are widely used in hospitals and clinics, catering to both domestic and international markets. The company’s focus on innovation and quality has enabled it to compete effectively with global players in the nasogastric tube market.
Products:
Guangdong Baihe Medical Technology offers a range of nasogastric tubes made from medical-grade polyurethane. These tubes are designed for long-term use, with features such as a soft, flexible design and a blue developing line for easy X-ray visibility. The company’s products are known for their biocompatibility and minimal irritation to the patient.
Market Performance in 2021:
In 2021, Guangdong Baihe Medical Technology’s nasogastric tube business recorded a revenue of $7.20 million USD with a gross profit of $4.23 million USD, achieving a gross profit margin of 58.77%.